CDC Report Reveals Nearly Half of U.S. GLP-1 Users Alter Prescribed Regimen Due to Cost and Access
Rapid Read

CDC Report Reveals Nearly Half of U.S. GLP-1 Users Alter Prescribed Regimen Due to Cost and Access

What's Happening? A recent report from the Centers for Disease Control and Prevention (CDC) indicates that approximately 44% of U.S. adults using GLP-1 medications, such as Wegovy and Zepbound, have modified their prescribed usage. The most common alteration reported was skipping doses, cited by 28%
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.